116 related articles for article (PubMed ID: 20190843)
1. Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto-SCT successfully treated with combination therapy.
Fianchi L; Colosimo C; De Luca A; Pompucci A; Cattani P; Voso MT; LaRocca LM; Leone G; Pagano L
Bone Marrow Transplant; 2010 Nov; 45(11):1668-70. PubMed ID: 20190843
[No Abstract] [Full Text] [Related]
2. [Progressive multifocal leukoencephalopathy in a patient with acute myeloid leukaemia after allogeneic hematopoietic-cell transplantation].
Fernández-Ruiz M; de la Serna J; Ruiz J; López-Medrano F
Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):636-7. PubMed ID: 21696864
[No Abstract] [Full Text] [Related]
3. Progressive multifocal leukoencephalopathy after autologous peripheral blood stem cell transplantation in a patient with multiple myeloma treated with combination therapy.
Yokokawa K; Hisahara S; Matsuura Y; Ikeda K; Tsuda E; Saitoh M; Nakamichi K; Saijo M; Kamihara Y; Sato T; Kawamata J; Shimohama S
J Neurol Sci; 2016 Sep; 368():304-6. PubMed ID: 27538654
[No Abstract] [Full Text] [Related]
4. A case of severe cutaneous, GI and liver GVHD in a patient with multiple myeloma, status-post-second auto-SCT.
Goddard DS; Ruben BS; Mathes ED; Nixon M; Wolf J; Fox LP
Bone Marrow Transplant; 2010 Feb; 45(2):409-11. PubMed ID: 19597426
[No Abstract] [Full Text] [Related]
5. Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature.
Kharfan-Dabaja MA; Ayala E; Greene J; Rojiani A; Murtagh FR; Anasetti C
Bone Marrow Transplant; 2007 Jan; 39(2):101-7. PubMed ID: 17143300
[TBL] [Abstract][Full Text] [Related]
6. [Progressive multifocal leukoencephalopathy in a case of myeloma].
Navarro V; Rapado A; Capote L; Ruíz F; De la Barreda P
Rev Clin Esp; 1973 Nov; 131(4):319-26. PubMed ID: 4772783
[No Abstract] [Full Text] [Related]
7. Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma: long-term follow-up.
Shimoni A; Hardan I; Ayuk F; Schilling G; Atanackovic D; Zeller W; Yerushalmi R; Zander AR; Kroger N; Nagler A
Cancer; 2010 Aug; 116(15):3621-30. PubMed ID: 20564132
[TBL] [Abstract][Full Text] [Related]
8. A prospective randomized trial of two popular mononuclear cell collection sets for autologous peripheral blood stem cell collection in multiple myeloma.
Cooling L; Hoffmann S; Herrst M; Muck C; Armelagos H; Davenport R
Transfusion; 2010 Jan; 50(1):100-19. PubMed ID: 19719472
[TBL] [Abstract][Full Text] [Related]
9. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review.
Hahn T; Wingard JR; Anderson KC; Bensinger WI; Berenson JR; Brozeit G; Carver JR; Kyle RA; McCarthy PL
Biol Blood Marrow Transplant; 2003 Jan; 9(1):4-37. PubMed ID: 12533739
[TBL] [Abstract][Full Text] [Related]
10. Severe autologous GVHD after hematopoietic progenitor cell transplantation for multiple myeloma.
Drobyski WR; Hari P; Keever-Taylor C; Komorowski R; Grossman W
Bone Marrow Transplant; 2009 Jan; 43(2):169-77. PubMed ID: 18762759
[TBL] [Abstract][Full Text] [Related]
11. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
Gertz MA; Lacy MQ; Inwards DJ; Chen MG; Pineda AA; Gastineau DA; Greipp PR; Lust JA; Tefferi A; Witzig TE; Kyle RA; Litzow MR
Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252
[TBL] [Abstract][Full Text] [Related]
12. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple Myeloma.
Harousseau JL; Attal M; Divine M; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M; Abgrall JF
Stem Cells; 1995 Aug; 13 Suppl 2():132-9. PubMed ID: 8520502
[TBL] [Abstract][Full Text] [Related]
13. [High-dose therapy of multiple myeloma with autologous hematopoietic stem cell transplantation and subsequent maintenance therapy with interferon alfa versus interferon alfa and dexamethasone--a randomized clinical study "4W"].
Mareschová I
Vnitr Lek; 1997 May; 43(5):345. PubMed ID: 9601862
[No Abstract] [Full Text] [Related]
14. Plasma cell leukemia 3 months after autologous blood cell transplantation for multiple myeloma.
Koskela K; Pelliniemi TT; Lakkala T; Remes K
Bone Marrow Transplant; 1998 Feb; 21(3):305-7. PubMed ID: 9489657
[TBL] [Abstract][Full Text] [Related]
15. [Outcome of bortezomib plus chemotherapy with or without stem cell transplantation for treatment of multiple myeloma].
Wang YF; Deng SH; Wu T; Xu Y; Zou DH; Wang Y; Zhao YZ; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):397-400. PubMed ID: 19031743
[TBL] [Abstract][Full Text] [Related]
16. Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.
Carreras E; Rosiñol L; Terol MJ; Alegre A; de Arriba F; García-Laraña J; Bello JL; García R; León A; Martínez R; Peñarrubia MJ; Poderós C; Ribas P; Ribera JM; San Miguel J; Bladé J; Lahuerta JJ;
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1448-54. PubMed ID: 18022574
[TBL] [Abstract][Full Text] [Related]
17. Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report.
Ruiz-Heredia Y; Sanchez-Vega B; Barrio S; Linares M; Rapado I; Braggio E; Stewart K; Folgueira MD; Ramos A; Collado L; Ruiz J; Toldos O; Hernandez-Lain A; Martinez-Lopez J
J Oncol Pharm Pract; 2019 Jun; 25(4):998-1002. PubMed ID: 29690814
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcal meningitis following autologous stem cell transplantation in a patient with multiple myeloma.
Mendpara SD; Ustun C; Kallab AM; Mazzella FM; Bilodeau PA; Jillella AP
Bone Marrow Transplant; 2002 Aug; 30(4):259-60. PubMed ID: 12203144
[No Abstract] [Full Text] [Related]
19. IgD multiple myeloma--a clinical profile and outcome with chemotherapy and autologous stem cell transplantation.
Wechalekar A; Amato D; Chen C; Keith Stewart A; Reece D
Ann Hematol; 2005 Feb; 84(2):115-7. PubMed ID: 15503021
[TBL] [Abstract][Full Text] [Related]
20. Autologous blood stem cell transplantation (ABSCT) in high-risk myeloma (MM).
Marit G; Boiron JM; Pico JL; Foures C; Rice A; Cony-Makhoul P; Bernard P; Broustet A; Reiffers J
Bone Marrow Transplant; 1991; 7 Suppl 2():29. PubMed ID: 1678977
[No Abstract] [Full Text] [Related]
[Next] [New Search]
